Carol M. Kopp edits features on a wide range of subjects for Investopedia, including investing, personal finance, retirement planning, taxes, business management, and career development. Investopedia ...

NAD expands its Classic Series with the C 3030 and C 3030S integrated amps, pairing retro VU-meter design with 50W amplification, HDMI eARC, and BluOS streaming on the C 3030S. Power: 50W into 8 ohms ...

NAD launches the C 3030 and C 3030S integrated amplifiers, blending vintage design with modern features, priced from $1,199 to $1,499. Visually, the cues are deliberate and unmistakable: VU meters, a ...

In this episode of Depths of History, the host explores a 1908 homestead, using the Minelab CTX 3030 metal detector to uncover silver coins and various relics. The journey continues to a Civil War ...

KANSAS CITY, Kan., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing ...

Ritwik is a passionate gamer who has a soft spot for JRPGs. He's been writing about all things gaming for six years and counting. No matter how great a title's gameplay may be, there's always the ...

Randomized phase II trial investigating whether atezolizumab after chemoradiotherapy (CRT) prolongs survival in limited stage (LS) small cell lung cancer (SCLC). Perioperative nivolumab (NIVO) vs ...

(RTTNews) - Cingulate Inc.(CING), a biopharmaceutical company, Tuesday reported positive results from the Phase 3 pediatric study of its lead drug candidate CTx-1301 for the treatment of Attention ...

Cingulate Inc. completes FDA Pre-NDA meeting for ADHD drug CTx-1301 and secures $3 million grant for anxiety treatment CTx-2103. Cingulate Inc. announced the successful completion of a Pre-NDA meeting ...

KANSAS CITY, Kan., April 29, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...